COR vs CAH — Key Metrics

Metric COR (CENCORA INC) CAH (CARDINAL HEALTH INC)
Price348.31278.32
Market Cap66.47 Billion64.33 Billion
P/E (TTM)25.7635.82
P/B (Quarterly)19.841-20.464
P/S (TTM)0.20.25
Net Profit Margin (TTM)0.80.7
Gross Margin (TTM)4.03.9
ROE (TTM)106.4-62.6
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

CENCORA INC
vs
 
CARDINAL HEALTH INC
 
CENCORA INC
vs
 
CARDINAL HEALTH INC
Performance Comparison
AI Model Recommendation
COR · CENCORA INC

Outperform

53
UnderperformOutperform
CAH · CARDINAL HEALTH INC

Greatly Outperform

64
UnderperformOutperform
Recommendation Summary

Stock COR is projected to outperform the market, stock CAH is projected to greatly outperform the market. Upfront Recommendation: CAH.

Financial Metrics
Prices delayed ~15 min
COR Metrics CAH
$348.31 Price $278.32
— Market Capitalization —
25.76 Price to Earnings Ratio 35.82
0.2 Price to Sales 0.25
16.19 Price to FCF Ratio 13.0
5.03 Price to Gross Profit 6.4
1.2 Price to Current Assets 1.57

COR vs CAH at a glance

Cencora INC (COR) and Cardinal Health INC (CAH) are both Medical Distribution companies in the Healthcare sector. They are similar in size: $66.5 billion and $64.3 billion in market value.

On trailing-twelve-month figures, COR trades at 25.8 times trailing earnings and CAH at 35.8; net profit margins are 0.8% and 0.7%.

The Upfront Investment model currently rates COR Outperform and CAH Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.